FDA Awards ICON with Project Validating PROs

Article

ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.

ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.